Clinical Trials Logo

Skin Diseases clinical trials

View clinical trials related to Skin Diseases.

Filter by:

NCT ID: NCT06037187 Recruiting - Clinical trials for Autoimmune Bullous Dermatosis

Coagulopathy of Immunodermatologic Diseases

Start date: May 9, 2023
Phase:
Study type: Observational

This study will examine the coagulation and fibrinolysis profiles of those with autoimmune skin diseases. Blood samples will be collected from participants with active/poorly controlled immune-mediated skin diseases and mild/latent/well-controlled immune-mediated skin diseases. A one-time sample from 15 general dermatology outpatients who do not have a known or suspected diagnosis of bullous diseases, immune-mediated dermatologic condition, or cutaneous malignancy will also be collected to serve as control. Blood samples from both participant populations will be analyzed for coagulation and inflammatory markers and compared. The results of this study may help inform future studies on the utility of analyzing coagulation and fibrinolysis profiles of patients with autoimmune skin diseases.

NCT ID: NCT06035614 Completed - Autoimmune Diseases Clinical Trials

Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

Vitiligo is a auto immune that impact 2% of the global population, regardless from the phototype. Even though it affects patients in a physical way through loss of pigmentation, it is also impacting them on a mental/emotional way.11-12 Current treatments offer a symptomatic solution to patients, however the response rate can be low and results can be slow. Pediatric patients in vitiligo deserves special care as frequently (50%), the disease onset is before 20 years of age and, in 25% of the cases, it starts before the age of 10 years.13 Also, the current treatments for children are limited since it can involve pain and claustrophobia. The combination therapy of the study could offer a painless and easy treatment to follow. If the combination of those two therapies can fasten and improve the response rate, this could be a good option to treat this condition not only in children, but also for adults patients.

NCT ID: NCT06023303 Completed - Clinical trials for Dermatologic Conditions

Prospective Clinical Study to Assess Safety and to Collect Data on Radiofrequency Microneedling Device(s) For the Purpose of Evaluating Treatment on Skin

Start date: June 21, 2023
Phase: N/A
Study type: Interventional

The goal of the Radiofrequency microneedling devices (Potenza and Morpheus) used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.

NCT ID: NCT06002685 Recruiting - Inflammation Clinical Trials

Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention

Start date: October 9, 2023
Phase: N/A
Study type: Interventional

The goal of this randomized controlled trial is to evaluate the impacts of an attachment-based intervention (Attachment Biobehavioral Catch-Up (ABC) and Home Book-of-the-Week (HBOW) program on emerging health outcomes (i.e., common childhood illnesses, body mass index, and sleep) in low-income Latino children (N=260; 9 months at enrollment). It is hypothesized that children randomized to ABC will have better health outcomes in comparison to the HBOW control group.

NCT ID: NCT05994976 Recruiting - Atopic Dermatitis Clinical Trials

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Start date: October 17, 2023
Phase:
Study type: Observational

The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.

NCT ID: NCT05988567 Completed - Skin Condition Clinical Trials

Efficacy Testing of Melon Oil Olive Pressed Candy Products

Start date: May 9, 2023
Phase: N/A
Study type: Interventional

To assess melon and oil olive pressed candy on skin condition improvement

NCT ID: NCT05988554 Completed - Skin Condition Clinical Trials

Efficacy Testing of Hibiscus Sabdariffa Extract and Collagen Products

Start date: June 5, 2023
Phase: N/A
Study type: Interventional

To assess Hibiscus sabdariffa extract and collagen products on skin condition improvement

NCT ID: NCT05987319 Recruiting - Wrinkle Clinical Trials

Feasibility Study to Collect and Assess Safety Data for a Radiofrequency Microneedling Device for Electrocoagulation and Hemostasis of Soft Tissues for Dermatologic Conditions

Start date: July 24, 2023
Phase: N/A
Study type: Interventional

The goal of the Potenza device used in this study is to collect clinical data for dermatologic conditions in which electrocoagulation and hemostasis is a viable mechanism for means of improvement.

NCT ID: NCT05928169 Recruiting - Psoriasis Clinical Trials

Determinants of Chronic Inflammatory Skin Disease Trajectories

Start date: May 1, 2023
Phase:
Study type: Observational

Although it is well known that the clinical expression and course of chronic inflammatory skin diseases are highly variable, there are insufficient epidemiological data on this, and the factors that determine the manifestation, clinical features and course are also largely unknown. There are currently no reliable markers that could predict or delineate patient subgroups to support patient management. The aim of this project is to identify clinical and molecular factors that correlate with disease, disease subtypes and progression through in-depth long-term clinical characterization of patients with chronic inflammatory skin diseases and examination of individual biomaterials.

NCT ID: NCT05919810 Active, not recruiting - Acne Vulgaris Clinical Trials

The Effects of Oral Probiotics and Herbal Supplementation on the Gut Microbiome and Sebum Excretion Rate in Non-Cystic Acne

Start date: July 3, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluates how probiotics and dietary supplementation with an herbal powder can shift the gut microbiome in those with non-cystic acne vulgaris.